We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
276
Magnetar Financial
Illinois
– -$222K -4,112 Closed
B
277
Bailard
California
– -$216K -4,009 Closed
CI
278
Cigna Investments
Connecticut
– -$210K -3,905 Closed
Lazard Asset Management
279
Lazard Asset Management
New York
– -$195K -3,626 Closed
LTFS
280
Ladenburg Thalmann Financial Services
Florida
– -$191K -3,526 Closed
AP
281
Advisor Partners
California
– -$222K -3,468 Closed
IUHSA
282
Itau Unibanco Holding S.A.
Brazil
– -$182K -3,380 Closed
TWA
283
TCI Wealth Advisors
Arizona
– -$176K -3,265 Closed
CG
284
Cutler Group
California
– -$150K -2,784 Closed
AWM
285
Avior Wealth Management
Nebraska
– -$139K -2,570 Closed
CIBC Private Wealth Group
286
CIBC Private Wealth Group
Georgia
– -$131K -2,437 Closed
AG
287
Advisor Group
Arizona
– -$118K -2,173 Closed
AAIM
288
American Assets Investment Management
California
– -$108K -2,000 Closed
AAM
289
Advisors Asset Management
Colorado
– -$107K -1,979 Closed
Robeco Institutional Asset Management
290
Robeco Institutional Asset Management
Netherlands
– -$105K -1,946 Closed
Fifth Third Bancorp
291
Fifth Third Bancorp
Ohio
– -$105K -1,945 Closed
Fuller & Thaler Asset Management
292
Fuller & Thaler Asset Management
California
– -$97K -1,800 Closed
RWA
293
Ropes Wealth Advisors
Massachusetts
– -$94K -1,737 Closed
FMT
294
First Mercantile Trust
Tennessee
– -$92K -1,700 Closed
BBHC
295
Brown Brothers Harriman & Co
New York
– -$80K -1,487 Closed
STA
296
Summit Trail Advisors
New York
– -$114K -1,460 Closed
RFC
297
Regions Financial Corp
Alabama
– -$78K -1,438 Closed
QT
298
Quantbot Technologies
New York
– -$66K -1,233 Closed
FHA
299
First Horizon Advisors
Tennessee
– -$71K -1,220 Closed
SWP
300
Stratos Wealth Partners
Ohio
– -$59K -1,093 Closed
10 11
12
13 14

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.